Sign In
About ASHM | Careers | Your Cart Shoppint Cart
Skip Navigation LinksASHM Internet Home > Gilead offers $250,000 in Research Grants

Gilead offers $250,000 in Research Grants

News; Job |
  |
  |
  |
  |
ASHM |
  |
ashm |
The Gilead Australia Fellowship is offering up to $250,000 to fund research projects in HIV, viral hepatitis or haematological oncology.

The Gilead Australia Fellowship is offering up to $250,000 to fund research projects in HIV, viral hepatitis or haematological oncology.

Project Areas

Research proposals are invited that explore and address the following issues and themes:

HIV/Chronic Hepatitis

  • Developing and/or evaluating novel ways to prevent new HIV and/or chronic viral hepatitis infections
  • Improving community and primary care awareness, interest and uptake of screening to identify undiagnosed people with HIV and/or chronic viral hepatitis in high prevalence populations
  • Reducing late diagnosis
  • Improving access, uptake and adherence to medication, with emphasis on marginalised groups such as Indigenous communities, drug users and immigrants
  • Developing strategies to support the management of long-term complications
  • Identifying the reasons for and strategies to reduce patients being lost to follow-up
  • Improving adherence to long-term medication through innovative programs

Haematological Oncology

  • Improving the care of patients with haematological malignancies

Who can apply?

Applications are encouraged from researchers at Australian hospitals, clinics, universities, research institutes and professional organisations, including:

  • Clinical and academic staff
  • Young investigators
  • Nurses
  • GPs
  • Other healthcare providers / researchers

Key Dates

Applications will close on 31 August 2016. Projects must be completed by the end of 2017.

Applications

All applications must be submitted online via the Gilead Australa Fellowship website www.gileadfellowship.com.au

Please enter a valid E-mail.
This must match your colleagues E-mail.
Please enter your name.
Please enter a valid email.
This must match your email.